Cargando…
Relation of Cardiovascular Risk Factors to Mortality and Cardiovascular Events in Hospitalized Patients With Coronavirus Disease 2019 (from the Yale COVID-19 Cardiovascular Registry)
Individuals with established cardiovascular disease or a high burden of cardiovascular risk factors may be particularly vulnerable to develop complications from coronavirus disease 2019 (COVID-19). We conducted a prospective cohort study at a tertiary care center to identify risk factors for in-hosp...
Autores principales: | Pareek, Manan, Singh, Avinainder, Vadlamani, Lina, Eder, Maxwell, Pacor, Justin, Park, Jakob, Ghazizadeh, Zaniar, Heard, Alex, Cruz-Solbes, Ana Sofia, Nikooie, Roozbeh, Gier, Chad, Ahmed, Zain V., Freeman, James V., Meadows, Judith, Smolderen, Kim G.E., Lampert, Rachel, Velazquez, Eric J., Ahmad, Tariq, Desai, Nihar R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849530/ https://www.ncbi.nlm.nih.gov/pubmed/33539857 http://dx.doi.org/10.1016/j.amjcard.2021.01.029 |
Ejemplares similares
-
Association of obesity with venous thromboembolism and myocardial injury in COVID-19
por: Wang, Stephen Y., et al.
Publicado: (2021) -
Depression and Screening Cardiovascular Events
por: Smolderen, Kim G., et al.
Publicado: (2008) -
The Future is Now: Frontiers on Display at Yale-NAVBO Cardiovascular Inflammation and Remodeling Symposium 2014
por: Wong, Albert, et al.
Publicado: (2014) -
Pathogenic Mechanisms Shared between Psoriasis and Cardiovascular Disease
por: Ghazizadeh, Ramin, et al.
Publicado: (2010) -
Moving toward combination lipid-lowering therapy for all patients with atherosclerotic cardiovascular disease
por: Faridi, Kamil F., et al.
Publicado: (2023)